|
|
5775 West Old Shakopee Road, Suite 100
Bloomington, MN 55437 USA
phone:(952) 346-4700
fax:(952) 346-4800
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.mgipharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Acquires oncology-focused pharmaceutical products. |
|
| Management |
| Lonnel Coats, President and COO; Judee Shuler, Director Corporate Planning and Communications; Robert (Bob) Feeney, Director Investor and Government Relations |
| |
|
|
| |
|
| Keywords |
| oncology, cancer, acute care |
|
|
|
| Description |
|
MGI Pharma, Inc. is an oncology and acute care focused biopharmaceutical company that acquires, researches, develops and commercializes proprietary products that address the unmet needs of patients. |
|
| Products / Services |
MGI Pharma markets Aloxi (palonosetron hydrochloride) injection and Gliadel (polifeprosan 20 with carmustine implant) Wafer in the United States.
|
|
| Market / Customers |
The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members